ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Bypassing Endocytic Barriers: Visualizing Membrane Fusion and Endosomal Escape of Cubic Phase Lipid Nanoparticles (Cubosomes).
Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- From Morphology to Mechanism: Cryo-Electron Microscopy Insights into Lipid Nanoparticles for RNA Delivery.ACS nano · 2026Review
- Engineered lipid hybrid nanoparticles for targeted delivery of SH2 superbinder and breast cancer therapy.Journal of nanobiotechnology · 2026Article
- Bypassing Endocytic Barriers: Visualizing Membrane Fusion and Endosomal Escape of Cubic Phase Lipid Nanoparticles (Cubosomes).Small (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lipid nanoparticles (LNPs) are versatile platforms for drug delivery, offering solutions for targeted therapeutics, gene therapy, and vaccines. Cubosomes - cubic phase lipid nanoparticles - exhibit unique structural properties that may allow direct cytosolic delivery, bypassing endocytic pathways that often limit intracellular drug delivery. Despite their potential, the mechanisms of cubosome interactions with mammalian cells, particularly their membrane fusion behavior, remain unclear. This study employs a multimodal microscopy-based approach to investigate cubosome interactions with cells, focusing on membrane fusion, lipid exchange, and endosomal escape. Advanced imaging techniques, including transmission, scanning, and cryogenic scanning electron microscopy, and live-cell fluorescence imaging, are used alongside tailored cubosome variants to examine interactions at micro- and nanoscale dimensions. Cubosome behaviors are compared to other nanoparticleslike liposomes and gold nanoparticles. For the first time, membrane fusion with mammalian plasma and endosomal membranes is visualized at the nanoscale, revealing how cubosomes bypass conventional endocytic pathways to deliver cargo directly into the cytosol. This work provides critical insights into LNP-cell interactions, establishing cubosomes as promising candidates for overcoming endosomal escape limitations in drug delivery. These findings will aid in developing next-generation lipid-based nanocarriers, particularly for RNA therapeutics, where efficient cytosolic delivery is essential for therapeutic efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.